Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Withdrawal of Artificial Nutrition at the End of Life (PERCEPAL) (PERCEPAL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02900573
Recruitment Status : Completed
First Posted : September 14, 2016
Last Update Posted : September 14, 2016
Sponsor:
Information provided by (Responsible Party):
Centre Hospitalier Régional Metz-Thionville

Brief Summary:
Withdrawing artificial nutrition in palliative care is an issue that often leads to ethical dilemmas among health care providers, despite clinical guidelines.

Condition or disease
Palliative Care Nursing

Detailed Description:

The benefit of artificial nutrition in terminally ill patients has been a highly debated issue for the past 30 years, and abundant data are available regarding its effects on patients. Several clinical guidelines have specified the criteria to be considered before initiating artificial nutrition or hydration. If these guidelines appear consensual in theory, the situation is much less straightforward in practice. The attitude of physicians appeared very variable when it came to prescribing or withholding artificial nutrition or hydration, and the lack of training, among other parameters, seemingly encouraged health care professionals to prescribe artificial nutrition or hydration. Furthermore, the decision of the care provider is unconsciously complicated due to figurative representations associated with food regarding, among other aspects, the mother-child relationship, social cohesion, or religious beliefs.

These differences are more important since the opinion of physicians and nurses is the one that carries the most influence on the patients' decision when deciding to initiate artificial nutrition and because artificial nutrition and hydration are a common source of ethical dilemmas in health care teams. Furthermore, stopping artificial nutrition or hydration could be misconstrued as euthanasia.


Layout table for study information
Study Type : Observational
Actual Enrollment : 289 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Caregivers Confronted With the Withdrawal of Artificial Nutrition at the End of Life: Perception and Experienced Difficulties
Study Start Date : May 2010
Actual Primary Completion Date : August 2010
Actual Study Completion Date : August 2010

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Palliative Care




Primary Outcome Measures :
  1. Experience of health care providers confronted with the withdrawing of artificial nutrition at the end of life [ Time Frame: month 4 ]
    Cross-sectional survey questionnaire


Secondary Outcome Measures :
  1. Experienced difficulties [ Time Frame: month 4 ]
    Cross-sectional survey questionnaire



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Senior nurses (which are not directly in contact with the patient but involved in team management), nurses (which perform patient care), and nurses' aides (which are involved in hygiene measures) working in the medicine, surgery, and palliative care departments of the regional hospital of Metz-Thionville.
Criteria

Inclusion Criteria:

  • nurses, and nurses' aides working in medicine, surgery, and palliative care departments of the regional hospital of Metz-Thionville

Exclusion Criteria:

  • Care providers working in pediatrics, gynecology and obstetrics, psychiatry, and emergency departments

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02900573


Locations
Layout table for location information
France
CHR Metz-Thionville
Metz Cedex 03, France, 57085
Sponsors and Collaborators
Centre Hospitalier Régional Metz-Thionville
Investigators
Layout table for investigator information
Principal Investigator: Benoît LEHEUP, MD CHR Metz-Thionville

Layout table for additonal information
Responsible Party: Centre Hospitalier Régional Metz-Thionville
ClinicalTrials.gov Identifier: NCT02900573     History of Changes
Other Study ID Numbers: 2010-01Obs-CHRMT
First Posted: September 14, 2016    Key Record Dates
Last Update Posted: September 14, 2016
Last Verified: August 2016
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No